Tag: euglycemic DKA
SGLT2 Inhibitors and Diabetic Ketoacidosis: Serious Risk Overview
SGLT2 inhibitors like Jardiance and Farxiga carry a risk of euglycemic diabetic ketoacidosis (euDKA), a condition where DKA occurs with normal blood sugar levels. Learn the symptoms, triggers, and safety guidelines to prevent this serious complication.